Biological properties of a new fluorescent biphalin fragment analogue

被引:10
作者
Lipkowski, AW
Misicka, A
Kosson, D
Kosson, P
Lachwa-From, M
Brodzik-Bienkowska, A
Hruby, VJ [1 ]
机构
[1] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA
[2] Polish Acad Sci, Med Res Ctr, PL-02106 Warsaw, Poland
[3] Ind Chem Res Inst, PL-01793 Warsaw, Poland
[4] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland
关键词
analgesia; opioid peptides; fluorescence probe;
D O I
10.1016/S0024-3205(01)01467-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Previous studies of structure- activity of biphalin defined fragments which expressed the full biological potency of the parent compound. The most simple fragment was Tyr-D-Ala-Gly-Phe-NH-NH<--X, where X=Phe, but it also could be other hydrophobic amino acids. This paper presents data that replacement of the phenylalanine with a dansyl (X=DNS) groups gives an analogue (AA2016) that fully preserves the high affinity of the initial analogue for both R and 8 opioid receptors. In the tail flick test in rats, intrathecal injection of the compound produces strong antinociception, comparable to the parent biphalin. Because AA2016 contains a strong fluorescent group, it can be a very useful tool for prospective studies in vivo, including biological barrier permeability, tissue distribution, metabolism and receptor-ligand complex formation. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:893 / 897
页数:5
相关论文
共 16 条
  • [1] Abbruscato TJ, 1996, J PHARMACOL EXP THER, V276, P1049
  • [2] Receptor-induced internalization of selective peptidic mu and delta opioid ligands
    Gaudriault, G
    Nouel, D
    DalFarra, C
    Beaudet, A
    Vincent, JP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (05) : 2880 - 2888
  • [3] HORAN PJ, 1993, J PHARMACOL EXP THER, V265, P1446
  • [4] Modifications of the 4,4′-residues and SAR studies of biphalin, a highly potent opioid receptor active peptide
    Li, GG
    Haq, W
    Xiang, L
    Lou, BS
    Hughes, R
    De Leon, IA
    Davis, P
    Gillespie, TJ
    Romanowski, M
    Zhu, XY
    Misicka, A
    Lipkowski, AW
    Porreca, F
    Davis, TP
    Yamamura, HI
    O'Brien, DF
    Hruby, VJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) : 555 - 560
  • [5] Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin
    Lipkowski, AW
    Misicka, A
    Davis, P
    Stropova, D
    Janders, J
    Lachwa, M
    Porreca, F
    Yamamura, HI
    Hruby, VJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (18) : 2763 - 2766
  • [6] BIVALENT OPIOID PEPTIDE ANALOGS WITH REDUCED DISTANCES BETWEEN PHARMACOPHORES
    LIPKOWSKI, AW
    KONECKA, AM
    SROCZYNSKA, I
    PRZEWLOCKI, R
    STALA, L
    TAM, SW
    [J]. LIFE SCIENCES, 1987, 40 (23) : 2283 - 2288
  • [7] DOUBLE-ENKEPHALINS - SYNTHESIS, ACTIVITY ON GUINEA-PIG ILEUM, AND ANALGESIC EFFECT
    LIPKOWSKI, AW
    KONECKA, AM
    SROCZYNSKA, I
    [J]. PEPTIDES, 1982, 3 (04) : 697 - 700
  • [8] Maszczynska I, 1998, LETT PEPT SCI, V5, P395, DOI 10.1007/BF02443494
  • [9] TOPOGRAPHICAL REQUIREMENTS FOR DELTA-OPIOID LIGANDS - COMMON STRUCTURAL FEATURES OF DERMENKEPHALIN AND DELTORPHIN
    MISICKA, A
    LIPKOWSKI, AW
    HORVATH, R
    DAVIS, P
    KRAMER, TH
    YAMAMURA, HI
    HRUBY, VJ
    [J]. LIFE SCIENCES, 1992, 51 (13) : 1025 - 1032
  • [10] Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
    Misicka, A
    Lipkowski, AW
    Horvath, R
    Davis, P
    Porreca, F
    Yamamura, HI
    Hruby, VJ
    [J]. LIFE SCIENCES, 1997, 60 (15) : 1263 - 1269